Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu Hengda Pharmaceutical is a prominent Chinese pharmaceutical manufacturer and a core subsidiary of the Hainan Asia Pharmaceutical Group. Established in 1995 and located in Chengdu's Jintang Industrial Park, the company focuses on the large-scale production of chemical formulations and Traditional Chinese Medicines (TCM). It is best known as the primary manufacturing site for the Quick (Kuaike) brand, which is one of China's most recognized over-the-counter (OTC) treatments for the common cold and influenza. The company operates modern, GMP-certified facilities capable of producing tablets, capsules, and granules at high volumes. In addition to respiratory products, its portfolio includes medications for bacterial infections, diabetes, and cardiovascular health. The company plays a vital role in the regional economy and the national supply chain for essential medicines in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu Hengda Pharmaceutical.